This article is more than 5 years old. Information may no longer be current.

Children’s Hospital of Philadelphia appoints section chief

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Stephan A. Grupp , MD, PhD, has been named chief of the section of cellular therapy and transplant within the division of oncology at Children’s Hospital of Philadelphia.

Name

Grupp, whose research has focused on innovative T-cell therapy for children with acute lymphoblastic leukemia, will assume the position on June 1.

“Dr. Grupp was the top candidate for this crucial position, and will now expand an already outstanding program that is revolutionizing cell therapy for children with resistant relapsed or refractory ALL and pioneering new strategies for stem cell transplantation,” Stephen P. Hunger, MD, chief of pediatric oncology and director of the Center for Childhood Cancer Research at CHOP, said in a press release.

Grupp has served as attending physician and oncology researcher at CHOP since 1996. He also is professor of pediatrics at University of Pennsylvania’s Perelman School of Medicine.